indoxyl has been researched along with Cardiovascular Diseases in 2 studies
*Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcidiacono, T; Avino, M; Belloni, C; Bisegna, S; Bologna, A; Conte, F; Foligno, N; Locatelli, M; Macrina, L; Magni, G; Palmieri, N; Premaschi, S; Simonini, M; Slaviero, G; Vezzoli, G | 1 |
| Manikandan, A; Moharil, P; Muñoz-Garay, C; Sathishkumar, M; Sivakumar, A | 1 |
2 other study(ies) available for indoxyl and Cardiovascular Diseases
| Article | Year |
|---|---|
Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients.
Topics: Biomarkers; Calcium; Cardiovascular Diseases; Cresols; Heart Disease Risk Factors; Humans; Indican; Indoles; Minerals; Phosphates; Renal Dialysis; Risk Factors; Sulfates; Sulfuric Acid Esters | 2022 |
Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypertension; Indoles; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thrombolytic Therapy | 2017 |